Connect
MJA
MJA

Migraine: a brain state amenable to therapy

Michael Eller and Peter J Goadsby
Med J Aust 2020; 212 (1): . || doi: 10.5694/mja2.50435
Published online: 13 January 2020

Summary

  • Migraine affects over a billion people worldwide in any year and is the second most common cause of years lost due to disability. Not “just a headache”, morbidity washes though society and carries a substantial economic and social cost.
  • Understanding of migraine pathophysiology has progressed significantly. Animal models and functional neuroimaging have yielded significant insight into brain structures that mediate migraine symptoms. The role of small peptides as neurotransmitters within this network has been elucidated, allowing the generation of novel therapeutic approaches that have been validated by randomised placebo‐controlled trials.
  • Migraine is underdiagnosed and undertreated. Treatment of migraine should be proactive. An acute and, when indicated, preventive strategy should be formulated with the patient. Comorbid medication overuse must be supportively managed.
  • Migraine‐specific medications are making their way from bench to bedside. They promise an improved safety profile and ease of use in comparison to older, repurposed medications. Devices promise a non‐drug alternative should patients prefer. The migraine understanding and treatment landscape is changing rapidly.
  • Michael Eller1
  • Peter J Goadsby2

  • 1 Monash Medical Centre, Melbourne, VIC
  • 2 UCSF Headache Center, San Francisco, CA, USA

Correspondence: peter.goadsby@ucsf.edu

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.